HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kennichi Kakudo Selected Research

Uridine Monophosphate (UMP)

3/2021Additional Tissue Sampling Trials Did Not Change Our Thyroid Practice.
8/2018How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.
3/2012Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer.
1/2012Classification of thyroid follicular cell tumors: with special reference to borderline lesions.
1/2012Cytological features of well-differentiated tumors of uncertain malignant potential: Indeterminate cytology and WDT-UMP.
1/2011Encapsulated follicular thyroid tumor with equivocal nuclear changes, so-called well-differentiated tumor of uncertain malignant potential: a morphological, immunohistochemical, and molecular appraisal.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kennichi Kakudo Research Topics

Disease

53Neoplasms (Cancer)
08/2021 - 01/2002
25Carcinoma (Carcinomatosis)
01/2022 - 06/2002
22Breast Neoplasms (Breast Cancer)
12/2007 - 01/2002
17Papillary Thyroid Cancer
01/2022 - 04/2003
14Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2003
11Lymphatic Metastasis
11/2017 - 02/2003
10Thyroiditis
01/2021 - 04/2005
9Papillary Carcinoma
08/2018 - 11/2002
7Adenoma (Adenomas)
03/2021 - 11/2002
6Neoplasm Metastasis (Metastasis)
02/2014 - 03/2002
6Fibrosis (Cirrhosis)
08/2012 - 09/2009
6Lymphoma (Lymphomas)
10/2006 - 01/2003
5Immunoglobulin G4-Related Disease
10/2020 - 09/2009
5Adenocarcinoma
01/2019 - 10/2002
5Hypothyroidism
08/2012 - 03/2010
5Goiter
01/2012 - 11/2002
4Follicular Adenocarcinoma
01/2022 - 01/2010
3Anaplastic Thyroid Carcinoma
01/2022 - 01/2010
3Inflammation (Inflammations)
10/2020 - 01/2007
2Thyroid Nodule (Nodule, Thyroid)
06/2021 - 03/2021
2Thyroid Diseases (Thyroid Disease)
01/2021 - 10/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2016 - 01/2005
2Stomach Neoplasms (Stomach Cancer)
08/2012 - 06/2002
2Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
03/2010 - 09/2009
2Subacute Thyroiditis (Thyroiditis, De Quervain)
09/2009 - 04/2005
2Carcinogenesis
05/2006 - 11/2002
2Medullary Carcinoma
06/2005 - 01/2005
2Chronic Thyroiditis
03/2004 - 01/2004
2Ductal Carcinoma
11/2002 - 01/2002
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2021
1Hyperthyroidism
06/2021
1Graves Disease (Basedow Disease)
01/2021
1Hashimoto Disease (Thyroiditis, Hashimoto)
10/2020
1Drug-Related Side Effects and Adverse Reactions
10/2020

Drug/Important Bio-Agent (IBA)

9Immunoglobulin G (IgG)IBA
01/2021 - 09/2009
9Proteins (Proteins, Gene)FDA Link
04/2015 - 11/2002
8Messenger RNA (mRNA)IBA
04/2015 - 06/2002
8Biological ProductsIBA
12/2010 - 11/2002
6Uridine Monophosphate (UMP)IBA
03/2021 - 01/2011
5ParaffinIBA
02/2014 - 06/2002
4RacivirIBA
01/2022 - 01/2010
4IodineIBA
08/2021 - 01/2015
4Calcitonin (Calcitonin, Eel)FDA LinkGeneric
11/2018 - 04/2006
4ThyroglobulinFDA Link
11/2017 - 09/2005
4AntibodiesIBA
04/2011 - 06/2002
4AcidsIBA
08/2009 - 01/2002
4Vascular Endothelial Growth Factor DIBA
04/2006 - 02/2003
4Estrogen ReceptorsIBA
11/2003 - 05/2002
4RetinoidsIBA
04/2003 - 01/2002
3Methotrexate (Mexate)FDA LinkGeneric
07/2021 - 01/2002
3Monoclonal AntibodiesIBA
03/2020 - 01/2003
3AutoantibodiesIBA
08/2012 - 04/2011
3Biomarkers (Surrogate Marker)IBA
02/2006 - 07/2002
3Vascular Endothelial Growth Factor CIBA
02/2006 - 04/2003
3fragile histidine triad proteinIBA
09/2002 - 07/2002
3Thymidine PhosphorylaseIBA
07/2002 - 01/2002
2prolinedithiocarbamate (PDTC)IBA
01/2022 - 02/2014
2Immunoglobulins (Immunoglobulin)IBA
01/2020 - 04/2011
2Immune Checkpoint InhibitorsIBA
05/2018 - 10/2017
2Plasminogen Activators (Plasminogen Activator)IBA
11/2014 - 04/2006
2Cadherins (E-Cadherin)IBA
08/2012 - 07/2010
2Indicators and Reagents (Reagents)IBA
04/2011 - 10/2002
2Retinoid X Receptors (Retinoid X Receptor)IBA
03/2011 - 04/2003
2Thyroid HormonesIBA
01/2010 - 09/2005
2PeriostinIBA
01/2010 - 08/2009
2Peptides (Polypeptides)IBA
08/2009 - 11/2006
2AdrenomedullinIBA
08/2009 - 11/2006
2Mitogen-Activated Protein KinasesIBA
12/2007 - 01/2007
2Transcription Factors (Transcription Factor)IBA
05/2006 - 09/2003
2NitritesIBA
04/2006 - 02/2006
2Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2006 - 02/2006
2NitratesIBA
04/2006 - 02/2006
23-nitrotyrosineIBA
04/2006 - 02/2006
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
04/2006 - 07/2005
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
11/2005 - 03/2004
2Carrier Proteins (Binding Protein)IBA
06/2005 - 09/2003
2Calcium-Binding ProteinsIBA
01/2005 - 01/2004
2Polo-Like Kinase 1IBA
01/2005 - 01/2004
2VimentinIBA
04/2004 - 06/2002
2Progesterone Receptors (Progesterone Receptor)IBA
12/2003 - 11/2003
2EnzymesIBA
12/2003 - 06/2002
2Hormones (Hormone)IBA
12/2003 - 03/2002
2Cyclin-Dependent Kinase Inhibitor p27IBA
09/2003 - 06/2003
2Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
04/2003 - 02/2003
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2003 - 03/2002
2Capsules (Microcapsules)IBA
01/2003 - 11/2002
2retinoic acid receptor betaIBA
11/2002 - 09/2002
2Histidine (L-Histidine)FDA Link
07/2002 - 01/2002
2Fluorouracil (Carac)FDA LinkGeneric
02/2002 - 01/2002
2TamoxifenFDA LinkGeneric
02/2002 - 01/2002
1Thyroxine (Levothyroxine)FDA LinkGeneric
06/2021
1Codon (Codons)IBA
06/2021
1Cyclic AMP (AMP, Cyclic)IBA
06/2021
1Anaplastic Lymphoma KinaseIBA
01/2019
1alectinibIBA
01/2019

Therapy/Procedure

15Therapeutics
01/2021 - 01/2002
10Thyroidectomy
08/2021 - 04/2005
5Drug Therapy (Chemotherapy)
01/2019 - 02/2002
1Conservative Treatment
08/2021
1Immunotherapy
10/2020